Differences

This shows you the differences between two versions of the page.

--- stocks:report-2018-04-17 [2018/04/17 13:19]
+++ stocks:report-2018-04-17 [2018/04/17 13:19] (current)
@@ Line 1: / Line 1: @@
+~~NOCACHE~~
+<html><script>var target=0.365; var supertarget=0.134</script></html>
+====== Stock Report ======
+>//Do not mistake temptation for opportunity.//
+Generated Tue Apr 17 09:19:04 EDT 2018.
+Ratings are relative rankings calculated by finding the lower bound of Wilson score confidence interval. A rating value close to 1 means a higher probablity of a stock's price high vs price open hitting or exceeding Calculated Target.
+====== Mood ======
+Today's mood: 0.4786859297829245
+====== Watched Stocks ======
+^ Symbol ^ Rating ^ Buy ^ Sell ^
+====== Leads ======
+These 16 stocks represent the top 2% of all considered stocks. 2% = 13
+^ Symbol ^ Rating ^ Buy ^ Sell ^ Mass ^ Min ^ Max ^ Mean ^ Median ^ Stdev ^ Open Vs High ^
+| [[#XRAY|⬇]][[	http://finance.yahoo.com/quote/XRAY|$XRAY]]((quote {symbol XRAY companyName {DENTSPLY SIRONA Inc.} primaryExchange {Nasdaq Global Select} sector Healthcare calculationPrice sip open 49.37 openTime 1523885400506 close 50.19 closeTime 1523908800163 high null low null latestPrice 50.74 latestSource {15 minute delayed price} latestTime {8:53:52 AM} latestUpdate 1523969632683 latestVolume 252 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 50.74 delayedPriceTime 1523969632683 previousClose 50.19 change 0.55 changePercent 0.01096 iexMarketPercent 0 iexVolume 0 avgTotalVolume 2258900 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 11536660794 peRatio 19.08 week52High 68.98 week52Low 48.25 ytdChange -0.2511481201863252})) | 0.871| 26| 0| 15| 0.046%| 4.072%| 1.233%| 0.851%| 1.202|
+| [[#SLB|⬇]][[	http://finance.yahoo.com/quote/SLB|$SLB]]((quote {symbol SLB companyName {Schlumberger N.V.} primaryExchange {New York Stock Exchange} sector Energy calculationPrice sip open 68.32 openTime 1523885400711 close 68.52 closeTime 1523908810173 high null low null latestPrice 68.52 latestSource {15 minute delayed price} latestTime {8:53:39 AM} latestUpdate 1523969619490 latestVolume 70267 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 68.52 delayedPriceTime 1523969619490 previousClose 68.52 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 7013000 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 94965783096 peRatio 45.68 week52High 80.35 week52Low 61.02 ytdChange -0.007428352898911802})) | 0.799| 30| 2| 44| 0.286%| 1.792%| 0.835%| 0.583%| 0.473|
+| [[#EBAY|⬇]][[	http://finance.yahoo.com/quote/EBAY|$EBAY]]((quote {symbol EBAY companyName {eBay Inc.} primaryExchange {Nasdaq Global Select} sector {Consumer Cyclical} calculationPrice sip open 40.22 openTime 1523885400164 close 40.19 closeTime 1523908800470 high null low null latestPrice 40.6 latestSource {15 minute delayed price} latestTime {8:51:39 AM} latestUpdate 1523969499330 latestVolume 4191 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 40.6 delayedPriceTime 1523969499330 previousClose 40.19 change 0.41 changePercent 0.0102 iexMarketPercent 0 iexVolume 0 avgTotalVolume 9464723 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 40348217111 peRatio 24.61 week52High 46.99 week52Low 31.89 ytdChange 0.055964266946925786})) | 0.785| 14| 0| 21| 0.505%| 2.769%| 1.264%| 1.377%| 0.651|
+| [[#NTAP|⬇]][[	http://finance.yahoo.com/quote/NTAP|$NTAP]]((quote {symbol NTAP companyName {NetApp Inc.} primaryExchange {Nasdaq Global Select} sector Technology calculationPrice sip open 68.15 openTime 1523885400690 close 68.27 closeTime 1523908800286 high null low null latestPrice 69.1 latestSource {15 minute delayed price} latestTime {9:00:27 AM} latestUpdate 1523970027328 latestVolume 99 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 69.1 delayedPriceTime 1523970027328 previousClose 68.27 change 0.83 changePercent 0.01216 iexMarketPercent 0 iexVolume 0 avgTotalVolume 2963712 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 18513459123 peRatio 29.03 week52High 69.1 week52Low 37.43 ytdChange 0.23684258202438524})) | 0.785| 14| 0| 20| 0.000%| 2.179%| 0.920%| 0.708%| 0.695|
+| [[#PEG|⬇]][[	http://finance.yahoo.com/quote/PEG|$PEG]]((quote {symbol PEG companyName {Public Service Enterprise Group Incorporated} primaryExchange {New York Stock Exchange} sector Utilities calculationPrice previousclose open 50.44 openTime 1523885400554 close 50.41 closeTime 1523908911112 high 50.61 low 50.01 latestPrice 50.41 latestSource {Previous close} latestTime {April 16, 2018} latestUpdate 1523836800000 latestVolume 3034298 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 50.327 delayedPriceTime 1523911962858 previousClose 50.41 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 3147777 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 25445188880 peRatio 17.2 week52High 53.28 week52Low 41.67 ytdChange -0.002052908418904247})) | 0.757| 12| 0| 2| 0.169%| 1.364%| 0.702%| 0.665%| 0.424|
+| [[#NUE|⬇]][[	http://finance.yahoo.com/quote/NUE|$NUE]]((quote {symbol NUE companyName {Nucor Corporation} primaryExchange {New York Stock Exchange} sector {Basic Materials} calculationPrice previousclose open 62.03 openTime 1523885400656 close 62.46 closeTime 1523908869747 high 62.64 low 61.62 latestPrice 62.46 latestSource {Previous close} latestTime {April 16, 2018} latestUpdate 1523836800000 latestVolume 1776623 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 62.46 delayedPriceTime 1523911326000 previousClose 62.46 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 2448056 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 19867986408 peRatio 17.59 week52High 70.48 week52Low 51.67 ytdChange -0.05507236729636633})) | 0.722| 10| 0| 25| 0.220%| 3.418%| 1.376%| 0.845%| 1.127|
+| [[#MRK|⬇]][[	http://finance.yahoo.com/quote/MRK|$MRK]]((quote {symbol MRK companyName {Merck & Company Inc. (new)} primaryExchange {New York Stock Exchange} sector Healthcare calculationPrice sip open 57.78 openTime 1523885411615 close 58.65 closeTime 1523908839753 high null low null latestPrice 59.75 latestSource {15 minute delayed price} latestTime {9:02:35 AM} latestUpdate 1523970155862 latestVolume 81276 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 59.75 delayedPriceTime 1523970155862 previousClose 58.65 change 1.1 changePercent 0.01876 iexMarketPercent 0 iexVolume 0 avgTotalVolume 12141673 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 160889705058 peRatio 15.01 week52High 66.41 week52Low 52.83 ytdChange 0.05234638254809574})) | 0.706| 78| 20| 271| 0.000%| 1.124%| 0.396%| 0.379%| 0.395|
+| [[#PPL|⬇]][[	http://finance.yahoo.com/quote/PPL|$PPL]]((quote {symbol PPL companyName {PPL Corporation} primaryExchange {New York Stock Exchange} sector Utilities calculationPrice sip open 27.91 openTime 1523885409900 close 28.06 closeTime 1523908946611 high null low null latestPrice 28.04 latestSource {15 minute delayed price} latestTime {8:54:10 AM} latestUpdate 1523969650286 latestVolume 500 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 28.04 delayedPriceTime 1523969650286 previousClose 28.06 change -0.02 changePercent -0.00071 iexMarketPercent 0 iexVolume 0 avgTotalVolume 7217275 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 19467510396 peRatio 12.46 week52High 40.2 week52Low 27.08 ytdChange -0.06919040131626968})) | 0.702| 14| 1| 6| 0.000%| 0.936%| 0.423%| 0.328%| 0.339|
+| [[#DISCA|⬇]][[	http://finance.yahoo.com/quote/DISCA|$DISCA]]((quote {symbol DISCA companyName {Discovery Inc. Series A Common Stock} primaryExchange {Nasdaq Global Select} sector {Consumer Cyclical} calculationPrice previousclose open 22.9 openTime 1523885400743 close 23.4 closeTime 1523908800447 high 23.465 low 22.46 latestPrice 23.4 latestSource {Previous close} latestTime {April 16, 2018} latestUpdate 1523836800000 latestVolume 4079380 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 23.4 delayedPriceTime 1523911300000 previousClose 23.4 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 5538056 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 11762420296 peRatio 11.76 week52High 30.25 week52Low 15.99 ytdChange 0.01254868022501078})) | 0.676| 8| 0| 3| 0.113%| 3.707%| 1.180%| 0.518%| 1.306|
+| [[#DWDP|⬇]][[	http://finance.yahoo.com/quote/DWDP|$DWDP]]((quote {symbol DWDP companyName {DowDuPont Inc.} primaryExchange {New York Stock Exchange} sector {Basic Materials} calculationPrice sip open 66.69 openTime 1523885418601 close 67.01 closeTime 1523908815366 high null low null latestPrice 67.5 latestSource {15 minute delayed price} latestTime {9:03:41 AM} latestUpdate 1523970221833 latestVolume 3015 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 67.5 delayedPriceTime 1523970221833 previousClose 67.01 change 0.49 changePercent 0.00731 iexMarketPercent 0 iexVolume 0 avgTotalVolume 9705606 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 157001302283 peRatio 48.91 week52High 77.08 week52Low 61.27 ytdChange -0.0632046760080579})) | 0.676| 8| 0| 9| 0.000%| 1.540%| 0.713%| 0.750%| 0.561|
+| [[#HAL|⬇]][[	http://finance.yahoo.com/quote/HAL|$HAL]]((quote {symbol HAL companyName {Halliburton Company} primaryExchange {New York Stock Exchange} sector Energy calculationPrice previousclose open 50.82 openTime 1523885400357 close 50.76 closeTime 1523908835509 high 51 low 50.07 latestPrice 50.76 latestSource {Previous close} latestTime {April 16, 2018} latestUpdate 1523836800000 latestVolume 6540593 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 50.81 delayedPriceTime 1523911608009 previousClose 50.76 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 8643869 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 44422616589 peRatio 41.61 week52High 57.86 week52Low 38.181 ytdChange 0.02717688244935946})) | 0.676| 8| 0| 14| 0.321%| 3.752%| 1.202%| 0.770%| 1.113|
+| [[#WING|⬇]][[	http://finance.yahoo.com/quote/WING|$WING]]((quote {symbol WING companyName {Wingstop Inc.} primaryExchange {Nasdaq Global Select} sector {Consumer Cyclical} calculationPrice sip open 48.81 openTime 1523885400579 close 51.09 closeTime 1523908800456 high null low null latestPrice 52.08 latestSource {15 minute delayed price} latestTime {8:49:56 AM} latestUpdate 1523969396361 latestVolume 50 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 52.08 delayedPriceTime 1523969396361 previousClose 51.09 change 0.99 changePercent 0.01938 iexMarketPercent 0 iexVolume 0 avgTotalVolume 449571 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 1518459687 peRatio 70.38 week52High 52.08 week52Low 27.785 ytdChange 0.3033362755552383})) | 0.676| 8| 0| 6| 0.000%| 3.251%| 1.449%| 0.893%| 1.291|
+| [[#MAC|⬇]][[	http://finance.yahoo.com/quote/MAC|$MAC]]((quote {symbol MAC companyName {Macerich Company (The)} primaryExchange {New York Stock Exchange} sector {Real Estate} calculationPrice sip open 57.94 openTime 1523885400503 close 57.85 closeTime 1523908922366 high null low null latestPrice 57.85 latestSource {15 minute delayed price} latestTime {8:36:04 AM} latestUpdate 1523968564289 latestVolume 38 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 57.85 delayedPriceTime 1523968564289 previousClose 57.85 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1288550 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 8148295026 peRatio 14.68 week52High 69.73 week52Low 52.12 ytdChange -0.12078592771142925})) | 0.610| 6| 0| 11| 0.227%| 2.378%| 0.920%| 0.896%| 0.603|
+| [[#NAV|⬇]][[	http://finance.yahoo.com/quote/NAV|$NAV]]((quote {symbol NAV companyName {Navistar International Corporation} primaryExchange {New York Stock Exchange} sector Industrials calculationPrice sip open 39.2 openTime 1523885566073 close 40.71 closeTime 1523908925309 high null low null latestPrice 41.58 latestSource {15 minute delayed price} latestTime {9:02:43 AM} latestUpdate 1523970163295 latestVolume 1005 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 41.58 delayedPriceTime 1523970163295 previousClose 40.71 change 0.87 changePercent 0.02137 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1151859 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 4103501718 peRatio 50.1 week52High 47.73 week52Low 23.02 ytdChange -0.06692642677057074})) | 0.610| 6| 0| 25| 0.024%| 6.706%| 1.392%| 0.769%| 1.941|
+| [[#DVA|⬇]][[	http://finance.yahoo.com/quote/DVA|$DVA]]((quote {symbol DVA companyName {DaVita Inc.} primaryExchange {New York Stock Exchange} sector Healthcare calculationPrice previousclose open 63.28 openTime 1523885447116 close 63.17 closeTime 1523908913323 high 63.42 low 62.32 latestPrice 63.17 latestSource {Previous close} latestTime {April 16, 2018} latestUpdate 1523836800000 latestVolume 1286347 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 63.17 delayedPriceTime 1523911309000 previousClose 63.17 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 1741498 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 11496940000 peRatio 18.36 week52High 80.71 week52Low 52.51 ytdChange -0.12917011304108084})) | 0.566| 5| 0| 10| 0.104%| 3.780%| 1.238%| 0.980%| 1.180|
+| [[#MRTN|⬇]][[	http://finance.yahoo.com/quote/MRTN|$MRTN]]((quote {symbol MRTN companyName {Marten Transport Ltd.} primaryExchange {Nasdaq Global Select} sector Industrials calculationPrice previousclose open 22.95 openTime 1523885400686 close 23.5 closeTime 1523908800261 high 23.65 low 22.95 latestPrice 23.5 latestSource {Previous close} latestTime {April 16, 2018} latestUpdate 1523836800000 latestVolume 460888 iexRealtimePrice 0 iexRealtimeSize 0 iexLastUpdated 0 delayedPrice 23.5 delayedPriceTime 1523912310047 previousClose 23.5 change 0 changePercent 0 iexMarketPercent 0 iexVolume 0 avgTotalVolume 317016 iexBidPrice 0 iexBidSize 0 iexAskPrice 0 iexAskSize 0 marketCap 1282334934 peRatio 37.9 week52High 29.6 week52Low 12.99 ytdChange 0.13372668020706183})) | 0.566| 5| 0| 3| n/a| n/a| n/a| n/a| n/a|
+===== $XRAY =====
+  * <nowiki>Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA Inc (NASDAQ: XRAY) and Dynavax (NASDAQ: DVAX) $XRAY https://t.co/cQ40sIbiSG</nowiki>
+  * <nowiki>5-star analyst Brandon Couillard from Jefferies reiterated a Buy on $XRAY.  https://t.co/K30lVTtZxs</nowiki>
+  * <nowiki>Dentsply Sirona $XRAY Earns Buy Rating from Jefferies Group  https://t.co/1kPZVzBaD1</nowiki>
+  * <nowiki>Dentsply Sirona $XRAY Earns Buy Rating from Jefferies Group https://t.co/DCuiXLAxxo</nowiki>
+  * <nowiki>Dentsply Sirona $XRAY Earns “Buy” Rating from Jefferies Group https://t.co/b7QID4cP8b #stocks</nowiki>
+  * <nowiki>$0.43 Earnings Per Share Expected for Dentsply Sirona $XRAY This Quarter https://t.co/orHezfJZ8U</nowiki>
+  * <nowiki>Dentsply Sirona $XRAY Expected to Announce Earnings of $0.43 Per Share https://t.co/82Ph8BysWW</nowiki>
+  * <nowiki>$947.20 Million in Sales Expected for Dentsply Sirona $XRAY This Quarter https://t.co/gV4RKEeXqo</nowiki>
+  * <nowiki>$947.20 Million in Sales Expected for Dentsply Sirona $XRAY This Quarter https://t.co/1CMmibIpIR</nowiki>
+  * <nowiki>Dentsply Sirona $XRAY Given “Buy” Rating at Jefferies Group https://t.co/yT96ZB4RnL</nowiki>
+  * <nowiki>Dentsply Sirona $XRAY Rating Reiterated by Jefferies Group https://t.co/pZgbgVtj74</nowiki>
+  * <nowiki>Jefferies Group Lowers Dentsply Sirona Q1 2018 Earnings Estimates to $0.43 EPS (Previously $0.47). https://t.co/fAt3nB2RvZ $XRAY #XRAY</nowiki>
+  * <nowiki>Jefferies Group Analysts Reduce Earnings Estimates for Dentsply Sirona $XRAY https://t.co/GbNCnov6Tm</nowiki>
+  * <nowiki>Jefferies Group Analysts Reduce Earnings Estimates for Dentsply Sirona $XRAY https://t.co/FFvqDjkZvx #stocks</nowiki>
+  * <nowiki>$NVCN Press Release from Feb 2018, March regained compliance with TSX, April Boston SCIENTIFIC, Warrants, May Earni… https://t.co/cDJ3uawHcd</nowiki>
+===== $SLB =====
+  * <nowiki>RT @ZacksResearch: David Bartosiak gives us the 5 best stocks to trade during the first week of earnings season. $NFLX $SLB $SKX $NUE $LRCX…</nowiki>
+  * <nowiki>David Bartosiak gives us the 5 best stocks to trade during the first week of earnings season. $NFLX $SLB $SKX $NUE… https://t.co/5omb3YXeKk</nowiki>
+  * <nowiki>#earnings scheduled for this week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG… https://t.co/LkN1AkojVv</nowiki>
+  * <nowiki>RT @ZacksResearch: David Bartosiak gives us the 5 best stocks to trade during the first week of earnings season. $NFLX $SLB $SKX $NUE $LRCX…</nowiki>
+  * <nowiki>$SLB Option Order Flow Sentiment is 58.5% Bullish. https://t.co/NF9fBZrueI</nowiki>
+  * <nowiki>Schlumberger $SLB Receives Average Rating of “Buy” from Brokerages https://t.co/vYM9bao4x9</nowiki>
+  * <nowiki>Schlumberger $SLB Receives Average Rating of “Buy” from Brokerages https://t.co/v2ezzb6Gpc</nowiki>
+  * <nowiki>Schlumberger $SLB Receives Average Rating of “Buy” from Brokerages https://t.co/oBJQW3Bvfc</nowiki>
+  * <nowiki>Big Call Activity https://t.co/B6IlNKq3kX $BHGE $WING $JD $SLB $WDC $TPX $IMAX $AMD $MDXG $GM $ALRM $LVS $IPG $AKRX $AMWD $OLED $TWTR $AAPL</nowiki>
+  * <nowiki>RT @permabear_uk: Schlumberger $SLB will be the first of the big energy stocks to report this Friday morning. I see a very positive uptick…</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>Schlumberger seeks to hike patent damages in case before Supreme Court https://t.co/yMd5C3gPWi $IO $SLB $OIH $XES</nowiki>
+  * <nowiki>RT @AscensionLP: There is a full slate of companies announcing earnings this week, as the banks continue with $BAC on Mon, $GS on Tues, and…</nowiki>
+  * <nowiki>Chop fest today. Should have traded less but oh well. Still like my $Slb calls going into earnings. With a close ab… https://t.co/djJq1RhjwQ</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>#Rally $GOOGL $FB $JPM $C $BAC $WFC $AAPL $PM $PG $GE $HON $JNJ $CSCO $MSFT $INTC $TWTR $TSLA $V $DIS $UNH $VZ $KHC… https://t.co/PB4tVzneis</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>Schlumberger $SLB Given Buy Rating at Instinet https://t.co/6vkCIyNR2k #stocks</nowiki>
+  * <nowiki>RT @BrandonVanZee: Prep your trading week with this excellent earnings graphic from @eWhispers!
+$JNJ $PG $NFLX $BAC $GE $LRCX $GS $UNH $I…</nowiki>
+  * <nowiki>$SLB bought the top here 1/30 I think, jun $75 Calls been averaging down like crazy still negative -55% tho, lets see wha rest of week bring</nowiki>
+  * <nowiki>RT @ZacksResearch: David Bartosiak gives us the 5 best stocks to trade during the first week of earnings season. $NFLX $SLB $SKX $NUE $LRCX…</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+Mon - $NFLX $BAC
+Tue - $CSX…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>RT @Terri1618: $SPY $QQQ $VLO $PSX updates. Slow grind up4 indices reflects indecisive mkt. Don’t force trades w/ sloppy price action. Ener…</nowiki>
+  * <nowiki>RT @Terri1618: $SPY $QQQ $VLO $PSX updates. Slow grind up4 indices reflects indecisive mkt. Don’t force trades w/ sloppy price action. Ener…</nowiki>
+  * <nowiki>$SPY $QQQ $VLO $PSX updates. Slow grind up4 indices reflects indecisive mkt. Don’t force trades w/ sloppy price act… https://t.co/RQlQFgB49y</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>Financial Survey: Schlumberger $SLB versus Basic Energy Services $BAS https://t.co/aeScI0smJm</nowiki>
+  * <nowiki>RT @Terri1618: $SPY $QQQ $VLO $PSX updates. Slow grind up4 indices reflects indecisive mkt. Don’t force trades w/ sloppy price action. Ener…</nowiki>
+  * <nowiki>Schlumberger $SLB Receives “Buy” Rating from Cowen https://t.co/VUdLM5mmjq</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>RT @Terri1618: $SPY $QQQ $VLO $PSX updates. Slow grind up4 indices reflects indecisive mkt. Don’t force trades w/ sloppy price action. Ener…</nowiki>
+  * <nowiki>RT @Terri1618: $SPY $QQQ $VLO $PSX updates. Slow grind up4 indices reflects indecisive mkt. Don’t force trades w/ sloppy price action. Ener…</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>RT @Terri1618: $SPY $QQQ $VLO $PSX updates. Slow grind up4 indices reflects indecisive mkt. Don’t force trades w/ sloppy price action. Ener…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>$SLB Schlumberger Option Order Flow Sentiment is 58.5% Bullish. https://t.co/NF9fBZrueI</nowiki>
+  * <nowiki>RT @Sarge986: Market Recon: Worried About the Trump Scandal? Buy Planet Fitness $XOM $HAL $SLB $PLNT IBM $CSX $LRCX $UAL  https://t.co/b4FR…</nowiki>
+  * <nowiki>Market Recon: Worried About the Trump Scandal? Buy Planet Fitness $XOM $HAL $SLB $PLNT IBM $CSX $LRCX $UAL  https://t.co/b4FREpW5Li</nowiki>
+===== $EBAY =====
+  * <nowiki>$EBAY New SEC Document(s) for eBay Inc.
+From our Stock News Alerts App</nowiki>
+  * <nowiki>$EBAY eBay Inc. SEC Filing: Form DEFA14A https://t.co/Fx84dGQ0KC</nowiki>
+  * <nowiki>Evening Most Tweeted Big Caps, check out Gambiste Top 10: $DBX $FAST $CHRW $COST $DISH $AAL $AKAM $EA $BIIB $EBAY https://t.co/lYp5LtitVR</nowiki>
+  * <nowiki>RT @WarrenBuffetHQ: No matter how fervently one desires to resolve a situation, sometimes it is better to patient and persevere with non-ac…</nowiki>
+  * <nowiki>RT @Decorporatize: Corps w/#h1b staff are #unAmerican. $INTC $DIS $GOOG $MSFT $IBM $QCOM $NVDA $JPM $AAPL $AMZN $MCD $ORCL $WFC $GS $BAC $H…</nowiki>
+  * <nowiki>Goldman Sachs looked at 25 tech stocks pulled down by $FB scandal and concludes that there is no connection between… https://t.co/dpMsUfX0Va</nowiki>
+  * <nowiki>$EBAY:
+New SEC Filing for EBAY: Form DEFA14A (No. 0001193125-18-118740):
+https://t.co/keqOv1Mxef</nowiki>
+  * <nowiki>$GBPUSD $NZDUSD $AUDUSD $EURUSD $SPY $QQQ $JPM $AAPL $AMD $YHOO $USDCAD $TSLA $BAC $ES_F $IBM $CHK $EBAY $WMT $WFC https://t.co/KHvtYikWK5</nowiki>
+  * <nowiki>Should investors apply to $RKUNY #Rakuten the same multiple they pay for $AMZN Amazon then $RKUNY #Rakuten should b… https://t.co/kf5eECDK5T</nowiki>
+  * <nowiki>eBay $EBAY Price Target Increased to $34.00 by Analysts at Canaccord Genuity https://t.co/GLVhNdOShT #stocks</nowiki>
+  * <nowiki>eBay $EBAY Upgraded to “Buy” by Monness Crespi &amp; Hardt https://t.co/FvfqHVSmjt</nowiki>
+  * <nowiki>eBay $EBAY Upgraded to “Buy” by Monness Crespi &amp; Hardt  https://t.co/Z92nUrz0p3</nowiki>
+  * <nowiki>Online sales tax ---&gt; nexus &lt;--- term of art.
+Tax accountants/lawyers matter.
+$AMZN $OSTK $EBAY $W</nowiki>
+  * <nowiki>John Blackledge previews large-cap Internet earnings $AMZN, $EBAY, $FB, $GOOG, $TWTR</nowiki>
+  * <nowiki>RT @PlanetZiggurat: https://t.co/VOEUjo0tbD   is open
+$AMZN $EBAY $MELI $ETSY $QVCA $BABA $WMT $COST $TGT $KR $JPM $FB $WFC $GOOG $SNAP $T…</nowiki>
+  * <nowiki>$WNTR big buyers coming in this month!
+$GERN $AMZN $NETE $RIOT $TEUM $PTI $COGT $GBLX $RXMD $VEND $GOPH $INTC… https://t.co/5Pfo5dh36a</nowiki>
+  * <nowiki>Finally starting to trend again $QQQ $SPY $NFLX $AAPL $INTC $EBAY lets go!</nowiki>
+===== $NTAP =====
+  * <nowiki>NetApp $NTAP versus Seagate Technology $STX Head to Head Comparison https://t.co/yXjzKcEqr0</nowiki>
+  * <nowiki>Head to Head Survey: NetApp $NTAP and Seagate Technology $STX https://t.co/BSkhNq4ZvL</nowiki>
+  * <nowiki>Head to Head Survey: NetApp $NTAP and Seagate Technology $STX https://t.co/o18e6BHT4B #stocks</nowiki>
+  * <nowiki>Head to Head Survey: NetApp $NTAP and Seagate Technology $STX https://t.co/8WPwmY3TIG</nowiki>
+  * <nowiki>$MU $WDC $CARB $NTAP $PSTG $STX $SGH https://t.co/IyVLHTggSh</nowiki>
+  * <nowiki>NetApp $NTAP Coverage Initiated by Analysts at JPMorgan Chase https://t.co/HO6SbRIY3v</nowiki>
+  * <nowiki>NetApp $NTAP Coverage Initiated by Analysts at JPMorgan Chase https://t.co/htH7NS4x8x</nowiki>
+  * <nowiki>5-star analyst Jason Ader from William Blair upgraded rating on $NTAP to Buy.  https://t.co/J8xAhn3nxH</nowiki>
+  * <nowiki>Upgrades $CCE $AXTI $ABB $PHG $TWTR $NTAP $NWL $MRK $DIS $KO $TRMB $DG</nowiki>
+  * <nowiki>RT @ACInvestorBlog: Upgrades $CCE $AXTI $ABB $PHG $TWTR $NTAP $NWL $MRK $DIS $KO $TRMB $DG</nowiki>
+  * <nowiki>RT @ACInvestorBlog: Upgrades $CCE $AXTI $ABB $PHG $TWTR $NTAP $NWL $MRK $DIS $KO $TRMB $DG</nowiki>
+  * <nowiki>Upgrades $CCE $AXTI $ABB $PHG $TWTR $NTAP $NWL $MRK $DIS $KO $TRMB $DG</nowiki>
+  * <nowiki>William Blair Upgrades NetApp to Outperform Rating $NTAP</nowiki>
+  * <nowiki>NetApp $NTAP Upgraded to Outperform by William Blair https://t.co/SGElzLqiAd #stocks</nowiki>
+  * <nowiki>Analyst upgrades NetApp; shares trading at 52-week high https://t.co/4fRpkkBvxu #premarket $NTAP</nowiki>
+  * <nowiki>Analyst upgrades NetApp; shares trading at 52-week high https://t.co/R7PIgqk5lc #premarket $NTAP</nowiki>
+  * <nowiki>Analyst upgrades NetApp; shares trading at 52-week high https://t.co/jN3bHmNmH7 #premarket $NTAP</nowiki>
+  * <nowiki>NetApp $NTAP Raised to Outperform at William Blair https://t.co/LP0EDmgIDa</nowiki>
+  * <nowiki>NetApp $NTAP Raised to Outperform at William Blair https://t.co/MwbdxIhg9I</nowiki>
+  * <nowiki>4/17 52-Week Hi Watch List: $LULU $STX $PXD $URBN $COP $APC $RTN $MLCO $PSX $MPC $NTAP $ADM $VLO $HES $MON $WLL… https://t.co/4Nf7QCFYYD</nowiki>
+===== $PEG =====
+  * <nowiki>Public Service Enterprise Group $PEG Upgraded by Bank of America to Buy https://t.co/9vuCyves4Y</nowiki>
+  * <nowiki>Public Service Enterprise Group $PEG Raised to Buy at Bank of America https://t.co/SQQEg8mWyP</nowiki>
+===== $NUE =====
+  * <nowiki>RT @ZacksResearch: David Bartosiak gives us the 5 best stocks to trade during the first week of earnings season. $NFLX $SLB $SKX $NUE $LRCX…</nowiki>
+  * <nowiki>David Bartosiak gives us the 5 best stocks to trade during the first week of earnings season. $NFLX $SLB $SKX $NUE… https://t.co/5omb3YXeKk</nowiki>
+  * <nowiki>RT @ZacksResearch: David Bartosiak gives us the 5 best stocks to trade during the first week of earnings season. $NFLX $SLB $SKX $NUE $LRCX…</nowiki>
+  * <nowiki>#earnings scheduled for this week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG… https://t.co/LkN1AkojVv</nowiki>
+  * <nowiki>RT @BrandonVanZee: Prep your trading week with this excellent earnings graphic from @eWhispers!
+$JNJ $PG $NFLX $BAC $GE $LRCX $GS $UNH $I…</nowiki>
+  * <nowiki>$NUE the bull pattern is confirmed &amp; a BUY signal is issued @ https://t.co/SSEzILYJCa. Buy Level: 62.2200   Target: 69.6864</nowiki>
+  * <nowiki>RT @ZacksResearch: David Bartosiak gives us the 5 best stocks to trade during the first week of earnings season. $NFLX $SLB $SKX $NUE $LRCX…</nowiki>
+  * <nowiki>Nucor $NUE Earns Buy Rating from Jefferies Group https://t.co/a7AJrdzsTz #stocks</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>Nucor $NUE to Release Quarterly Earnings on Thursday https://t.co/9dNqPTf7SE</nowiki>
+  * <nowiki>Nucor $NUE to Release Quarterly Earnings on Thursday https://t.co/vJ7Wvaketl</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>Nucor Co. $NUE Expected to Post Earnings of $1.10 Per Share https://t.co/k38NFon7lL</nowiki>
+  * <nowiki>Zacks: Analysts Anticipate Nucor Co. $NUE to Announce $1.10 Earnings Per Share  https://t.co/0Uab8h10kp</nowiki>
+  * <nowiki>Zacks: Analysts Anticipate Nucor Co. $NUE to Announce $1.10 Earnings Per Share https://t.co/JY5Yp3sTCU #stocks</nowiki>
+  * <nowiki>Zacks: Analysts Anticipate Nucor Co. $NUE to Announce $1.10 Earnings Per Share https://t.co/U6c1U9BfXA</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>RT @eWhispers: #earnings scheduled for the week
+$NFLX $BAC $GE $LRCX $GS $UNH $IBM $JNJ $CLF $MTB $ABT $MS $ISRG $PGR $CMA $PG $AA $BX $AX…</nowiki>
+  * <nowiki>Novid Rassouli previews #steel sector 1Q18 earnings. Focus includes recent pricing trends  $X, $MT, $AKS, $STLD, $RS, $NUE, $TMST, $CLF</nowiki>
+  * <nowiki>$BBT $NUE $BOJA:
+CBJ Morning Buzz: Could ruling impact SC’s fight with Amazon …:
+https://t.co/uNSueAWZb5</nowiki>
+  * <nowiki>$NUE:
+Is Nucor Shifting Its Growth Approach?:
+https://t.co/gbZeutPT26</nowiki>
+  * <nowiki>Target Raised https://t.co/2Wn5XwkMO6 $ICFI $INTC $JBHT $LULU $MA $MB $MNRO $MRK $MTB $NFLX $NUE $RHT $SCHW $STLD $THG $TPR $ULTI $VIAB</nowiki>
+===== $MRK =====
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>$MRK $BMY:
+What Happened in the Stock Market Today:
+https://t.co/G0RaqxLyCz</nowiki>
+  * <nowiki>Everything lung cancer! $MRK $BMY #AACR18 https://t.co/evJoPR7Jax</nowiki>
+  * <nowiki>RT @theflynews: On The Fly: Top stock stories for Monday $AMZN $CVS $WBA $ABC $MCK $CAH $TSLA $NFLX $BAC $WPP $ERI $TPCA $NAV $VLKAY $ACIA…</nowiki>
+  * <nowiki>Mad Money Lighting Round @jimcramer https://t.co/92gBWvX6Cn $SPOT $ALKS $JNJ $GERN $ILMN $TMO $AKS $SRNE $MITK $NVDA $KKR $FRPT $ABBV $MRK</nowiki>
+  * <nowiki>RT @JohnCendpts: $BMY not getting much love today -- $MRK in a TKO as analysts score the match.
+https://t.co/JHlLY14xxm</nowiki>
+  * <nowiki>RT @JacobPlieth: $MRK crushes $BMY (and perhaps $RHHBY too).  My take on today's #AACR18 showdown, via @EPVantage https://t.co/bgoFcCRa1g</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>#estate assets watch - heaviest volume today:  $BAC $GE $BMY $WFC $MU $YNDX $AMD $OCLR $MRK $F $AAPL $RIG $T $CVS… https://t.co/d5eAO7Xvcl</nowiki>
+  * <nowiki>@bradloncar @sharkbiotech so, per Bristol, $BMY's, $MRK's and like PD1s are not really differentiated in terms of clinical effect?</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>Bristol-Myers' Opdivo/Yervoy combo beats chemo in first-line lung cancer; shares down 5% on Merck Keytr... https://t.co/Ha37ljKTEs $BMY $MRK</nowiki>
+  * <nowiki>"There is no question this is a watershed period in the treatment of lung cancer" https://t.co/KQC6A8OUmo $MRK $BMY</nowiki>
+  * <nowiki>RT @JacobPlieth: $MRK crushes $BMY (and perhaps $RHHBY too).  My take on today's #AACR18 showdown, via @EPVantage https://t.co/bgoFcCRa1g</nowiki>
+  * <nowiki>RT @JacobPlieth: Take that, $BMY. Keytruda's knockout blow in 1st-line NSCLC? $MRK #AACR18 https://t.co/D39w38xTqr</nowiki>
+https://t.co/kJzr6EE5Ex…</nowiki>
+  * <nowiki>More Call Activity $FEYE $OSTK $COP $BABA $KHC $OMC $SCHW $NFLX $KNX $EDU $IVC $MRK $ENDP $FCAU $EPD $VLO $PBR $SPHS $NKTR $CTG $BX $WRD</nowiki>
+  * <nowiki>Big Call Activity https://t.co/B6IlNKq3kX $SCHW $NFLX $KNX $EDU $IVC $MRK $ENDP $FCAU $EPD $VLO $PBR $SPHS $NKTR $CTG $BX $WRD $ICE $JBHT</nowiki>
+  * <nowiki>RT @tradejas: $MRK Immunotherapy scores big win against lung cancer in study https://t.co/FZaIcaVB2M</nowiki>
+  * <nowiki>Biotech Updates 04/16:
+$BMY $MRK lung data
+$CLDX fail -65%
+FDA accepts $ALKS NDA
+$APRI -35% more trials required… https://t.co/tTP5zWxTmz</nowiki>
+  * <nowiki>RT @bydavidcrow: The story of Bristol vs Merck in one picture $BMY $MRK https://t.co/smszuY6F94</nowiki>
+  * <nowiki>Part of our strategy includes collaborating with partners to explore new approaches and therapy combinations that c… https://t.co/dnO74dVA7B</nowiki>
+  * <nowiki>RT @Merck: Looking forward to sharing our latest #cancer research development updates during our #AACR18 investor briefing! $MRK https://t.…</nowiki>
+  * <nowiki>RT @JohnCendpts: Tim Anderson on $MRK/$BMY brawl:
+$BMY had some decent numbers for one segment, $MRK did well for all. Bottom line: Keytrud…</nowiki>
+  * <nowiki>Looking forward to sharing our latest #cancer research development updates during our #AACR18 investor briefing!… https://t.co/YlRaOHgDJf</nowiki>
+  * <nowiki>RT @AndyBiotech: Novel sexy I/O players now have a mountain to climb vs $MRK chemo combo in lung cancer, plus Alimta going generic by 2022…</nowiki>
+  * <nowiki>We calculated 63-day Expected Return of $MRK for you: 0.6% https://t.co/y7B8KCv7tv</nowiki>
+  * <nowiki>$ONCS $MRK Keytruda + Oncosec ep-IL12 in lung cancer would be nice sometime in the future. https://t.co/KrCQti9har</nowiki>
+  * <nowiki>Today’s $mrk result in NSCLC just affirms to me that it is basically unethical to withhold clinical trial data of a… https://t.co/2UUIKhYKrc</nowiki>
+  * <nowiki>RT @MaxJacobsEdison: Maybe $MRK should rename their Pembro trials from KEYNOTE to PLENARY.</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>RT @megtirrell: $MRK data out; Keytruda reduced risk of death in trial by 51% https://t.co/YCSM062iia</nowiki>
+  * <nowiki>RT @drug_czar: Staggering data from $MRK. OS benefit seen in Intent-to-treat of 0.49 and also all patient subgroups including 0.59 HR in no…</nowiki>
+  * <nowiki>RT @JohnCendpts: Who won big at #AACR18? Merck surges on Keytruda/chemo combo while Bristol-Myers shares tumble on comparison
+$MRK +3%
+$BMY…</nowiki>
+  * <nowiki>Merck $MRK came out of its corner swinging Sunday morning, taking a few direct jabs at the defending champion in ch… https://t.co/Ku4zE4O9Dg</nowiki>
+  * <nowiki>$MRK $BMY The Merck vs. Bristol Myers battle isn't over yet, but Merck won today. https://t.co/IHeFBCQ88T</nowiki>
+  * <nowiki>RT @JohnCendpts: #AACR18 brawl. $MRK data: Keytruda/chemo reduces risk of death by 51% -- in high PD-L1 58%. HR of 0.49.
+https://t.co/4Kpcx…</nowiki>
+  * <nowiki>RT @JacobPlieth: Take that, $BMY. Keytruda's knockout blow in 1st-line NSCLC? $MRK #AACR18 https://t.co/D39w38xTqr</nowiki>
+  * <nowiki>Why Merck Is Betting Big on One Cancer Drug
+Global sales of more than $3.8 billion for Keytruda in 2017 spur effor… https://t.co/NArrmtoPcv</nowiki>
+  * <nowiki>RT @megtirrell: $MRK data out; Keytruda reduced risk of death in trial by 51% https://t.co/YCSM062iia</nowiki>
+  * <nowiki>$MRK Immunotherapy scores big win against lung cancer in study https://t.co/FZaIcaVB2M</nowiki>
+  * <nowiki>RT @drug_czar: Head still spinning from the IO showdown at #AACR18? To keep track of the data, I have a comparison of the PFS and OS hazard…</nowiki>
+  * <nowiki>$IMMP $MRK https://t.co/C7KqFIvqUB</nowiki>
+  * <nowiki>RT @VistaPResearch: Read "Positively Doubting Judgement?” Vista Partners Weekly Market Update 4-14-18 https://t.co/hg3CNxxgeF  #investing #…</nowiki>
+  * <nowiki>$MRK nice options flow..i see 1 put on the whole list https://t.co/b8X2eLt80N</nowiki>
+  * <nowiki>Shares of Bristol-Myers Squibb fell after its drug was surpassed by Keytruda’s performance.… https://t.co/0lgRNkSl3z</nowiki>
+  * <nowiki>RT @drug_czar: Head still spinning from the IO showdown at #AACR18? To keep track of the data, I have a comparison of the PFS and OS hazard…</nowiki>
+  * <nowiki>@drug_czar $MRK has a history of deceptive practices.  You can't trust them.  Here's one of many examples.  https://t.co/4qEQahWIuy</nowiki>
+  * <nowiki>$MRK regardless if you have a position or not, you have to truly appreciate what they have done with Keytruda. Amazing accomplishment @Merck</nowiki>
+  * <nowiki>RT @JohnCendpts: #AACR18 brawl. $MRK data: Keytruda/chemo reduces risk of death by 51% -- in high PD-L1 58%. HR of 0.49.
+https://t.co/4Kpcx…</nowiki>
+  * <nowiki>RT @theflynews: On The Fly: Top stock stories for Monday $AMZN $CVS $WBA $ABC $MCK $CAH $TSLA $NFLX $BAC $WPP $ERI $TPCA $NAV $VLKAY $ACIA…</nowiki>
+  * <nowiki>#estate asset watch - price / volume leaders today: $BAC $GE $BMY $WFC $MU $AMD $YNDX $OCLR $MRK $AAPL $F $T $RIG… https://t.co/V6HHzetULl</nowiki>
+  * <nowiki>Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://t.co/DKVRp58o9M #stockmarket #stocks #trading #DowJones</nowiki>
+  * <nowiki>Dow Jones Analysis Video - $DJIA $DIA $SDOW  $XOM $GE $GS $MRK $PFE $BMY $VZ https://t.co/tE01Lw1rzM #stockmarket #stocks #trading #DowJones</nowiki>
+  * <nowiki>RT @JohnCendpts: #2
+Who won big at #AACR18? Merck surges on Keytruda/chemo combo while Bristol-Myers shares tumble on comparison
+$MRK $BMY…</nowiki>
+  * <nowiki>RT @JohnCendpts: #3
+#AACR18 round 1: Merck takes a direct swing at Bristol-Myers with adjuvant melanoma data for Keytruda
+$MRK $BMY
+https:/…</nowiki>
+  * <nowiki>@Sanctuary_Bio The difference is $MRK has good revenue growth and will just grow faster with the 1L chemo+Keytruda… https://t.co/6AOeZv166q</nowiki>
+  * <nowiki>RT @JohnCendpts: $BMY not getting much love today -- $MRK in a TKO as analysts score the match.
+https://t.co/JHlLY14xxm</nowiki>
+  * <nowiki>RT @JacobPlieth: $MRK crushes $BMY (and perhaps $RHHBY too).  My take on today's #AACR18 showdown, via @EPVantage https://t.co/bgoFcCRa1g</nowiki>
+  * <nowiki>RT @matthewherper: My story on the $mrk $bmy data. Short version: $mrk wins again, despite strong $bmy results. https://t.co/0phBvFJd5m</nowiki>
+  * <nowiki>RT @JacobPlieth: OS and PFS curves in $MRK Keynote-189 by PD-L1 expression, via Leena Gandhi #AACR18 $BMY $RHHBY https://t.co/WGvS4jpAdd</nowiki>
+  * <nowiki>RT @JacobPlieth: Probably the most positive slide for $BMY in CM-227, via M Hellmann #AACR18 $MRK $RHHBY https://t.co/jWPi8Qx3ll</nowiki>
+  * <nowiki>RT @crusadernz: Biotech Updates 04/16:
+$BMY $MRK lung data
+$CLDX fail -65%
+FDA accepts $ALKS NDA
+$APRI -35% more trials required
+$CLVS -10…</nowiki>
+  * <nowiki>RT @JacobPlieth: Justin Gainor (Impower-150 discussant) compares KN-189 vs IMP-150. We LOVE cross-trial comparisons, right? $MRK $RHHBY $BM…</nowiki>
+  * <nowiki>RT @crusadernz: Biotech Updates 04/16:
+$BMY $MRK lung data
+$CLDX fail -65%
+FDA accepts $ALKS NDA
+$APRI -35% more trials required
+$CLVS -10…</nowiki>
+  * <nowiki>RT @Merck: “This year’s @AACR Annual Meeting represents an important milestone for immuno-oncology research and we’re extremely proud to ha…</nowiki>
+  * <nowiki>RT @Merck: “This year’s @AACR Annual Meeting represents an important milestone for immuno-oncology research and we’re extremely proud to ha…</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new… https://t.co/MBzG3oWQC5</nowiki>
+  * <nowiki>RT @Merck: “This year’s @AACR Annual Meeting represents an important milestone for immuno-oncology research and we’re extremely proud to ha…</nowiki>
+  * <nowiki>RT @Merck: Looking forward to sharing our latest #cancer research development updates during our #AACR18 investor briefing! $MRK https://t.…</nowiki>
+  * <nowiki>RT @Merck: “This year’s @AACR Annual Meeting represents an important milestone for immuno-oncology research and we’re extremely proud to ha…</nowiki>
+  * <nowiki>RT @Merck: “This year’s @AACR Annual Meeting represents an important milestone for immuno-oncology research and we’re extremely proud to ha…</nowiki>
+  * <nowiki>RT @Merck: Don't miss important new data from our #LungCancer study being presented today at #AACR18. Learn more here: https://t.co/DRFdeti…</nowiki>
+  * <nowiki>“This year’s @AACR Annual Meeting represents an important milestone for immuno-oncology research and we’re extremel… https://t.co/F59gQJw4oO</nowiki>
+  * <nowiki>RT @Merck: Looking forward to sharing our latest #cancer research development updates during our #AACR18 investor briefing! $MRK https://t.…</nowiki>
+  * <nowiki>In KEYNOTE-054, adjuvant treatment with $MRK's Keytruda of Stage 3 melanoma reduced the risk of disease recurrence… https://t.co/vLRcder2Od</nowiki>
+  * <nowiki>This is a stunning…Keytruda and Optiva are game-changers for lung (and probably other) cancer, and home-runs for… https://t.co/bMPJ6sosUk</nowiki>
+  * <nowiki>Slides from $MRK AACR investor webcast:
+https://t.co/FuG1GWrg5c</nowiki>
+  * <nowiki>$LPTX Reveals findings from study testing DKN-01 + $MRK 's KEYTRUDA in patients with advanced esophagogastric cancer https://t.co/k3lwjC7qkG</nowiki>
+  * <nowiki>$LPTX Reveals findings from study testing DKN-01 + $MRK 's KEYTRUDA in patients with advanced esophagogastric cance… https://t.co/4vbceutrCV</nowiki>
+  * <nowiki>RT @Merck: Don't miss important new data from our #LungCancer study being presented today at #AACR18. Learn more here: https://t.co/DRFdeti…</nowiki>
+  * <nowiki>One has to wonder how Nivo/Chemo compares with Pembro/Chemo. I suspect in CM-227 Part 1b, Nivo/chemo was no better… https://t.co/miAz9fXKE3</nowiki>
+  * <nowiki>Nothing was said about Part 1b, which compares nivo/ipi, Nivo/Chemo, and Chemo alone in PDL-1 - patients. This part… https://t.co/3sgN4jrMc5</nowiki>
+https://t.co/kJzr6EE5Ex…</nowiki>
+  * <nowiki>@megtirell Impressive results for $MRK &amp; $BMY in the battle against lung cancer. https://t.co/cEaDKvvZij</nowiki>
+  * <nowiki>RT @IBD_AGatlin: Can this smaller biotech actually rival Merck, Bristol in cancer drugs? $TSRO $MRK $BMY https://t.co/4XMvQlXf5t</nowiki>
+  * <nowiki>RT @JacobPlieth: OS and PFS curves in $MRK Keynote-189 by PD-L1 expression, via Leena Gandhi #AACR18 $BMY $RHHBY https://t.co/WGvS4jpAdd</nowiki>
+  * <nowiki>RT @JacobPlieth: OS and PFS curves in $MRK Keynote-189 by PD-L1 expression, via Leena Gandhi #AACR18 $BMY $RHHBY https://t.co/WGvS4jpAdd</nowiki>
+  * <nowiki>RT @crusadernz: Biotech Updates 04/16:
+$BMY $MRK lung data
+$CLDX fail -65%
+FDA accepts $ALKS NDA
+$APRI -35% more trials required
+$CLVS -10…</nowiki>
+  * <nowiki>RT @JacobPlieth: OS and PFS curves in $MRK Keynote-189 by PD-L1 expression, via Leena Gandhi #AACR18 $BMY $RHHBY https://t.co/WGvS4jpAdd</nowiki>
+  * <nowiki>RT @JacobPlieth: OS and PFS curves in $MRK Keynote-189 by PD-L1 expression, via Leena Gandhi #AACR18 $BMY $RHHBY https://t.co/WGvS4jpAdd</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>@gcbioinv @Kevvy_Kaye Hi, buddies. With today's $MRK and $BMY lung cancer data, I have a feeling that majority of o… https://t.co/D6YpmWReeN</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>RT @jonathanrockoff: $MRK up &gt;2.5%, while $BMY down &gt;8%, on lung-cancer immunotherapy news: https://t.co/PfjUipfQEr. Bernstein's Anderson s…</nowiki>
+  * <nowiki>RT @JacobPlieth: Justin Gainor (Impower-150 discussant) compares KN-189 vs IMP-150. We LOVE cross-trial comparisons, right? $MRK $RHHBY $BM…</nowiki>
+  * <nowiki>RT @JohnCendpts: #2
+Who won big at #AACR18? Merck surges on Keytruda/chemo combo while Bristol-Myers shares tumble on comparison
+$MRK $BMY…</nowiki>
+  * <nowiki>RT @JacobPlieth: $MRK crushes $BMY (and perhaps $RHHBY too).  My take on today's #AACR18 showdown, via @EPVantage https://t.co/bgoFcCRa1g</nowiki>
+  * <nowiki>Okay.  So $BMY = bad company &amp; great stock and, $MRK = Great company and bad stock.  I will never understand how '… https://t.co/RqDzvSlQ68</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @Ogut_Ozgur: Today’s $mrk result in NSCLC just affirms to me that it is basically unethical to withhold clinical trial data of approved…</nowiki>
+  * <nowiki>RT @JacobPlieth: Take that, $BMY. Keytruda's knockout blow in 1st-line NSCLC? $MRK #AACR18 https://t.co/D39w38xTqr</nowiki>
+  * <nowiki>RT @bydavidcrow: Here are my back of envelope comparisons on Merck and Bristol trials (I know, no cross trial comps yadayada, but everyone…</nowiki>
+  * <nowiki>RT @DewDiligence: Slides from $MRK AACR investor webcast:
+https://t.co/FuG1GWrg5c</nowiki>
+  * <nowiki>Recommendation #HOLD for $MRK with UB rating - 2.89 out of 5. https://t.co/QmN7roMsl8</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @BursatilBiotech: Gooooooooooooooooooooooooooood Morning, Deareeeeest Biotwitter!
+Toooooooooday is D-Day!
+disease, 3 COs, 3 trials
+$B…</nowiki>
+  * <nowiki>@Ogut_Ozgur As BMO put it: "Keytruda + chemo is the new standard of care in all ALK/EGFR negative noon-squamous 1L-… https://t.co/Mc1V0xgUiZ</nowiki>
+  * <nowiki>RT @AndyBiotech: #Biotech Busy week ahead!
+$RARE PDUFA
+$RIGL PDUFA
+$GWPH AdCom
+$INCY $LLY AdCom BD
+Earnings
+$JNJ
+$NVS
+#AACR18
+$BMY CM-227…</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @JacobPlieth: Probably the most positive slide for $BMY in CM-227, via M Hellmann #AACR18 $MRK $RHHBY https://t.co/jWPi8Qx3ll</nowiki>
+  * <nowiki>RT @JacobPlieth: $MRK crushes $BMY (and perhaps $RHHBY too).  My take on today's #AACR18 showdown, via @EPVantage https://t.co/bgoFcCRa1g</nowiki>
+  * <nowiki>RT @SA_BioTech: $AXON $BIIB $LLY $MRK $VTVT https://t.co/hPZRl4rPeM</nowiki>
+  * <nowiki>RT @AndyBiotech: #Biotech Busy week ahead!
+$RARE PDUFA
+$RIGL PDUFA
+$GWPH AdCom
+$INCY $LLY AdCom BD
+Earnings
+$JNJ
+$NVS
+#AACR18
+$BMY CM-227…</nowiki>
+  * <nowiki>$LPTX   $7.83 +0.34 (4.54%)   $MRK   $59.24 +0.59 (1.01%)  - News Out
+https://t.co/aSsM2rGugR</nowiki>
+  * <nowiki>Explore #fundamental numbers and pros and cons for $MRK https://t.co/RMKJb2hbiB</nowiki>
+  * <nowiki>#Merck Cements Lead in #Lungcancer With #BristolMyers Fizzling
+#Competition between #pharma is good for #patients… https://t.co/Bn0zKdCJSd</nowiki>
+  * <nowiki>RT @Merck: “This year’s @AACR Annual Meeting represents an important milestone for immuno-oncology research and we’re extremely proud to ha…</nowiki>
+  * <nowiki>Wondering about risks of $MRK? The 21-day volatility is 7.33% https://t.co/F24Y08wWlG</nowiki>
+  * <nowiki>RT @Merck: Looking forward to sharing our latest #cancer research development updates during our #AACR18 investor briefing! $MRK https://t.…</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>$MRK high OI range is 55.00 to 57.50 for option expiration 04/20/2018 #maxpain #options https://t.co/biZK1ZVXxB https://t.co/buidhxn7hO</nowiki>
+  * <nowiki>Wondering about risks of $MRK? The 63-day volatility is 12.7% https://t.co/F24Y08wWlG</nowiki>
+  * <nowiki>We calculated 63-day Expected Return of $MRK for you: 0.6% https://t.co/eHMiSmPb0G</nowiki>
+  * <nowiki>I bet the $ONCS partner to b announced soon will be $MRK.  Wouldn’t be surprised to ultimately see them combine key… https://t.co/QHVbzOSW1y</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>@JohnTuckerPhD @bradloncar It’s all trial design- $MRK said why beat chemo when you can join it. Blame $BMY for bei… https://t.co/KnLFt1EvFH</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @BioPharmaDive: In KEYNOTE-054, adjuvant treatment with $MRK's Keytruda of Stage 3 melanoma reduced the risk of disease recurrence or de…</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>@JSTBiotech I'm not worried about that. Part of the reason for the weakness is great $MRK data for CP + chemo.
+Anyo… https://t.co/4TPrzTj43u</nowiki>
+  * <nowiki>RT @AndyBiotech: #Biotech Busy week ahead!
+$RARE PDUFA
+$RIGL PDUFA
+$GWPH AdCom
+$INCY $LLY AdCom BD
+Earnings
+$JNJ
+$NVS
+#AACR18
+$BMY CM-227…</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @Merck: Looking forward to sharing our latest #cancer research development updates during our #AACR18 investor briefing! $MRK https://t.…</nowiki>
+  * <nowiki>RT @Merck: Part of our strategy includes collaborating with partners to explore new approaches and therapy combinations that could help peo…</nowiki>
+  * <nowiki>RT @AndyBiotech: #Biotech Busy week ahead!
+$RARE PDUFA
+$RIGL PDUFA
+$GWPH AdCom
+$INCY $LLY AdCom BD
+Earnings
+$JNJ
+$NVS
+#AACR18
+$BMY CM-227…</nowiki>
+  * <nowiki>RT @Merck: “This year’s @AACR Annual Meeting represents an important milestone for immuno-oncology research and we’re extremely proud to ha…</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>$MRK on watch</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>RT @JacobPlieth: $RHHBY Impower-150 PFS results by PD-L1 status, via Mark Socinski (note two different assays...) #AACR18 $MRK $BMY https:/…</nowiki>
+  * <nowiki>RT @JacobPlieth: OS and PFS curves in $MRK Keynote-189 by PD-L1 expression, via Leena Gandhi #AACR18 $BMY $RHHBY https://t.co/WGvS4jpAdd</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>RT @JacobPlieth: That's clear, right? (Matthew Hellmann, Checkmate-227 redesign.) #AACR18 $BMY $MRK $RHHBY https://t.co/agIwItrdCX</nowiki>
+  * <nowiki>RT @JacobPlieth: Probably the most positive slide for $BMY in CM-227, via M Hellmann #AACR18 $MRK $RHHBY https://t.co/jWPi8Qx3ll</nowiki>
+  * <nowiki>RT @JacobPlieth: OS and PFS curves in $MRK Keynote-189 by PD-L1 expression, via Leena Gandhi #AACR18 $BMY $RHHBY https://t.co/WGvS4jpAdd</nowiki>
+  * <nowiki>RT @Merck: Part of our strategy includes collaborating with partners to explore new approaches and therapy combinations that could help peo…</nowiki>
+  * <nowiki>RT @JacobPlieth: Take that, $BMY. Keytruda's knockout blow in 1st-line NSCLC? $MRK #AACR18 https://t.co/D39w38xTqr</nowiki>
+  * <nowiki>Research Analysts Offer Predictions for Merck &amp; Co.’s Q1 2018 Earnings $MRK  https://t.co/tn0qmtsdMN</nowiki>
+  * <nowiki>Research Analysts Offer Predictions for Merck &amp; Co.’s Q1 2018 Earnings $MRK https://t.co/N254C48l3y</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>RT @bydavidcrow: Here are my back of envelope comparisons on Merck and Bristol trials (I know, no cross trial comps yadayada, but everyone…</nowiki>
+  * <nowiki>RT @AndyBiotech: #Biotech Busy week ahead!
+$RARE PDUFA
+$RIGL PDUFA
+$GWPH AdCom
+$INCY $LLY AdCom BD
+Earnings
+$JNJ
+$NVS
+#AACR18
+$BMY CM-227…</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>$ALKS $BMY $JNJ $MRK https://t.co/8u9uVNGt0n</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>RT @JacobPlieth: Take that, $BMY. Keytruda's knockout blow in 1st-line NSCLC? $MRK #AACR18 https://t.co/D39w38xTqr</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>RT @endpts: Who won big at #AACR18? Merck surges on Keytruda/chemo combo while Bristol-Myers shares tumble on comparison https://t.co/zhvTj…</nowiki>
+  * <nowiki>RT @kjilly: #IO combos inch forward in #pharma's #lungcancer quest #biotech #biopharma #biotechnology #NSCLC #AACR18 #immunooncology #Opdiv…</nowiki>
+  * <nowiki>Who won big at #AACR18? Merck surges on Keytruda/chemo combo while Bristol-Myers shares tumble on comparison… https://t.co/wlpUREtYNC</nowiki>
+  * <nowiki>Read "Positively Doubting Judgement?” Vista Partners Weekly Market Update https://t.co/hg3CNxxgeF #investing… https://t.co/iAX3jLzftz</nowiki>
+  * <nowiki>RT @JohnCendpts: #AACR18 brawl. $MRK data: Keytruda/chemo reduces risk of death by 51% -- in high PD-L1 58%. HR of 0.49.
+https://t.co/4Kpcx…</nowiki>
+  * <nowiki>RT @SeekingAlpha: $ALKS $BMY $JNJ $MRK https://t.co/8u9uVNGt0n</nowiki>
+  * <nowiki>The past week $BMY had been going DOWN while $MRK had been creeping UP. Something tells me the cancer trial informa… https://t.co/G6rioVSzZW</nowiki>
+  * <nowiki>RT @JacobPlieth: $MRK crushes $BMY (and perhaps $RHHBY too).  My take on today's #AACR18 showdown, via @EPVantage https://t.co/bgoFcCRa1g</nowiki>
+  * <nowiki>RT @JacobPlieth: OS and PFS curves in $MRK Keynote-189 by PD-L1 expression, via Leena Gandhi #AACR18 $BMY $RHHBY https://t.co/WGvS4jpAdd</nowiki>
+  * <nowiki>Jefferies Group Reiterates $56.00 Price Target for Merck &amp; Co. $MRK https://t.co/NU4cNLyYJE</nowiki>
+  * <nowiki>RT @zbiotech: spectacular NEJM data $MRK 189 OS KM and subgroups https://t.co/8cQz63yFw3</nowiki>
+  * <nowiki>While everyone's chewing on the data and the Merck vs BMS / pembro vs nivo discussion, let's not forget about the i… https://t.co/wXneEoRnvL</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>@jq1234t @bradloncar A PD-L1+/- analysis of CM-227 be when $MRK Keytruda+chemo can be used in all-comers, and Keytr… https://t.co/9U1zzd4wea</nowiki>
+  * <nowiki>A loophole for $bmy in 1st line nsclc might be the relatively high number of patients with symptomatic brainmets. D… https://t.co/cnGoFDhjfJ</nowiki>
+  * <nowiki>RT @Ogut_Ozgur: Today’s $mrk result in NSCLC just affirms to me that it is basically unethical to withhold clinical trial data of approved…</nowiki>
+  * <nowiki>RT @drug_czar: Head still spinning from the IO showdown at #AACR18? To keep track of the data, I have a comparison of the PFS and OS hazard…</nowiki>
+  * <nowiki>RT @Ogut_Ozgur: Today’s $mrk result in NSCLC just affirms to me that it is basically unethical to withhold clinical trial data of approved…</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @DewDiligence: Slides from $MRK AACR investor webcast:
+https://t.co/FuG1GWrg5c</nowiki>
+  * <nowiki>Morgan Stanley Upgrades Merck $MRK to Overweight https://t.co/Cihq17yxzY</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>@jq1234t @bradloncar A PD-L1+/- analysis of CM-227 when $MRK Keytruda+chemo can be used in all-comers, and Keytruda… https://t.co/X4bqi6c38C</nowiki>
+  * <nowiki>RT @OpenOutcrier: $MRK (+0.5% pre) Merck’s KEYTRUDA® (pembrolizumab) Reduced the Risk of Disease Recurrence or Death by More than 40 Percen…</nowiki>
+  * <nowiki>RT @OpenOutcrier: $MRK (+0.5% pre) Why Merck Is Betting Big on One Cancer Drug - WSJ
+https://t.co/5vMoVT25L7</nowiki>
+  * <nowiki>Lung Cancer Patients Live Longer With Immune Therapy https://t.co/okEy7qE06W  $BMY $MRK</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>RT @AndyBiotech: #AACR18 first-line NSCLC I/O showdown in NEJM
+$MRK Keynote-189
+https://t.co/rkqySZYSLo
+$BMY Checkmate-227 TMB
+https://t…</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>#Premarket Top % Gainers: $ASFI 8%, $ROKU $NFLX $YANG $HMNY $TWTR $TQQQ $ZUO $DGAZ $YNDX $TEO $NOK $PHG $HMY $MRK $IQ $PSEC $SSO $BUD $SHPG</nowiki>
+  * <nowiki>RT @wboscoho: $BMY $MRK
+RT
+Lung Cancer Patients Live Longer With Immune Therapy https://t.co/2KjXaTWSqH</nowiki>
+  * <nowiki>$MRK upgraded to Overweight at Morgan Stanley. PT $68</nowiki>
+  * <nowiki>$BMY $MRK
+RT
+Lung Cancer Patients Live Longer With Immune Therapy https://t.co/2KjXaTWSqH</nowiki>
+  * <nowiki>RT @BioStocks: $MRK upgraded to Overweight at Morgan Stanley. PT $68</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>RT @drug_czar: With a week left to go, here's a preview of the Immunotherapy-combo showdown at #AACR18 where Keytruda, Opdivo, and Tecentri…</nowiki>
+  * <nowiki>Merck &amp; Co.’s $MRK “Buy” Rating Reaffirmed at BMO Capital Markets https://t.co/q0k1NytbBk</nowiki>
+  * <nowiki>RT @BioStocks: $MRK upgraded to Overweight at Morgan Stanley. PT $68</nowiki>
+  * <nowiki>RT @BioStocks: $MRK upgraded to Overweight at Morgan Stanley. PT $68</nowiki>
+  * <nowiki>$MRK upgraded to Overweight at Morgan Stanley. PT $68</nowiki>
+  * <nowiki>Baml $MRK emerging as clear IO leader in lung cancer
+raising Keytruda sales forecasts based on strength of Phase 3… https://t.co/FYpKjLZ3PF</nowiki>
+  * <nowiki>RT @drug_czar: Head still spinning from the IO showdown at #AACR18? To keep track of the data, I have a comparison of the PFS and OS hazard…</nowiki>
+  * <nowiki>RT @BobbyLandman121: Keynote189 vs IMpower150 comparison $MRK $AZN #AACR18 https://t.co/1AdTLNHLDj</nowiki>
+  * <nowiki>‘Keytruda is King’ in lung cancer, putting BMS and next-gen in the shade https://t.co/OILpNPRbjN #AACR18 $MRK $NKTR $BMS</nowiki>
+  * <nowiki>4/16/18
+#MadMoneyEspresso
+$C$JPM$BAC$WBA
+$CVS$COST$ULTA
+$GE… https://t.co/L4ofhMVbLm</nowiki>
+  * <nowiki>RT @wboscoho: $BMY $MRK
+RT
+Lung Cancer Patients Live Longer With Immune Therapy https://t.co/2KjXaTWSqH</nowiki>
+  * <nowiki>RT @Super1NYC: #Premarket Top % Gainers: $ASFI 8%, $ROKU $NFLX $YANG $HMNY $TWTR $TQQQ $ZUO $DGAZ $YNDX $TEO $NOK $PHG $HMY $MRK $IQ $PSEC…</nowiki>
+  * <nowiki>Upgrades $CCE $AXTI $ABB $PHG $TWTR $NTAP $NWL $MRK $DIS $KO $TRMB $DG</nowiki>
+  * <nowiki>RT @ACInvestorBlog: Upgrades $CCE $AXTI $ABB $PHG $TWTR $NTAP $NWL $MRK $DIS $KO $TRMB $DG</nowiki>
+  * <nowiki>RT @ACInvestorBlog: Upgrades $CCE $AXTI $ABB $PHG $TWTR $NTAP $NWL $MRK $DIS $KO $TRMB $DG</nowiki>
+  * <nowiki>https://t.co/2WASIf0beT
+$JNJ $PFE $MRK #earnings #pharmastock #Cancer #stocknews #Markets</nowiki>
+  * <nowiki>RT @bydavidcrow: Here are my back of envelope comparisons on Merck and Bristol trials (I know, no cross trial comps yadayada, but everyone…</nowiki>
+  * <nowiki>RT @bydavidcrow: Credit Suisse calls it for Merck $MRK $BMY https://t.co/mIhbsL4ePj</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @Super1NYC: #Premarket Top % Gainers: $ASFI 8%, $ROKU $NFLX $YANG $HMNY $TWTR $TQQQ $ZUO $DGAZ $YNDX $TEO $NOK $PHG $HMY $MRK $IQ $PSEC…</nowiki>
+  * <nowiki>RT @tgtxdough: LADEN $LPTX 2nd note LPTX Stock Drop After DKN-01+Keytruda AACR2018 Data Unwarranted; Reiterate Buy PT 18 $MRK #AACR18 https…</nowiki>
+  * <nowiki>RT @BioStocks: $MRK upgraded to Overweight at Morgan Stanley. PT $68</nowiki>
+  * <nowiki>RT @Merck: Our commitment to patients living with #lungcancer has never been stronger. Together we’ll continue to look for new ways to figh…</nowiki>
+  * <nowiki>RT @Super1NYC: #Premarket Top % Gainers: $ASFI 8%, $ROKU $NFLX $YANG $HMNY $TWTR $TQQQ $ZUO $DGAZ $YNDX $TEO $NOK $PHG $HMY $MRK $IQ $PSEC…</nowiki>
+  * <nowiki>RT @JacobPlieth: OS and PFS curves in $MRK Keynote-189 by PD-L1 expression, via Leena Gandhi #AACR18 $BMY $RHHBY https://t.co/WGvS4jpAdd</nowiki>
+  * <nowiki>Steve Scala publishes pharma sector investment takeaways from #AACR18 $MRK $BMY $AZN $RHHBY</nowiki>
+  * <nowiki>Further $LPTX commentary from Laden - treating physician called one patient's response "a miracle" and Merck $MRK "… https://t.co/yK5AqFdeCp</nowiki>
+  * <nowiki>RT @Merck: Looking forward to sharing our latest #cancer research development updates during our #AACR18 investor briefing! $MRK https://t.…</nowiki>
+  * <nowiki>RT @bydavidcrow: Merck’s stunning lung cancer trial makes FT front page. $MRK $BMY #AACR18 https://t.co/JnXMVqNZmX</nowiki>
+  * <nowiki>Merck &amp; Co. $MRK Upgraded to “Buy” by Morgan Stanley https://t.co/RFWxaLR3B6</nowiki>
+  * <nowiki>RT @tgtxdough: LADEN $LPTX 2nd note LPTX Stock Drop After DKN-01+Keytruda AACR2018 Data Unwarranted; Reiterate Buy PT 18 $MRK #AACR18 https…</nowiki>
+  * <nowiki>RT @tgtxdough: LADEN $LPTX 2nd note LPTX Stock Drop After DKN-01+Keytruda AACR2018 Data Unwarranted; Reiterate Buy PT 18 $MRK #AACR18 https…</nowiki>
+  * <nowiki>LADEN $LPTX 2nd note LPTX Stock Drop After DKN-01+Keytruda AACR2018 Data Unwarranted; Reiterate Buy PT 18 $MRK… https://t.co/Boe63UmTcn</nowiki>
+  * <nowiki>Merck &amp; Co. $MRK Upgraded to “Buy” by Morgan Stanley https://t.co/G9bAXnHVrw</nowiki>
+  * <nowiki>PM Top % Gainers: $CNET $DPW $ROKU $ARQL $NFLX $AVXL $TQQQ $IQ $DBX $TWTR $UNH $NOK $HMNY $SPXL $MRK $RAD $HMY $BUD $AMD</nowiki>
+  * <nowiki>Gainers   Premarket $ROKU $NFLX $TQQQ $TWTR $DGAX $UPRO $QLD $SPXL $NOK $UNH $MRK $TNA $AMD $BUD $SHPG $SSO
+https://t.co/jpobP3U3HN</nowiki>
+  * <nowiki>#TRADING US PM Gapers $NFLX $UNH $ROKU $SHPG $BUD $MRK $WPP $TWTR $RDS.A $PHG $YNDX $BAC $HMNY $AMD $NOK $HMY $BABA… https://t.co/dp6OhUSF3P</nowiki>
+  * <nowiki>RT @Super1NYC: #Premarket Top % Gainers: $CNET 30%, $DPW 15%, $ROKU $ARQL $NFLX $AVXL $TQQQ $IQ $DBX $TWTR $UNH $NOK $HMNY $SPXL $MRK $RAD…</nowiki>
+  * <nowiki>Upgrades $CCE $AXTI $ABB $PHG $TWTR $NTAP $NWL $MRK $DIS $KO $TRMB $DG</nowiki>
+  * <nowiki>$KTOV Highlights of TyrNovo's NT-219 recent promising results from Kitov last presentation #AACR18 $MRK $LLY https://t.co/9Yi3pa6CnV</nowiki>
+  * <nowiki>JPM currently assumes 45% mkt share for $MRK which could proove conservative, each additional 10% share bumps peak… https://t.co/qYCk3PTo4X</nowiki>
+  * <nowiki>GS - $BMY data was solid but significantly overshadowed by $MRK</nowiki>
+  * <nowiki>$NKTR Wainwright attributes selloff to belief that $MRK has first mover advantage in non-squamous NSCLC. Believes… https://t.co/IcqXdSpzDN</nowiki>
+  * <nowiki>$MRK Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine https://t.co/XUj8XMe0Kt</nowiki>
+  * <nowiki>$MRK:
+Merck Announces First Phase Three Studies for PCV-15 (V114) Its …:
+https://t.co/cPkzYUs8hm</nowiki>
+  * <nowiki>$MRK Pretty sure Merck was buying back their own shares last quarter. Merck going to $70 this year for sure. https://t.co/REtHfcs3yY</nowiki>
+  * <nowiki>$MRK Merck Announces First Phase Three Studies for PCV-15 (V114) Its Investigational Pneumococcal Disease Vaccine https://t.co/QJxt6U62z3</nowiki>
+  * <nowiki>RT @Super1NYC: #Premarket Top % Gainers: $CNET 30%, $DPW 15%, $ROKU $ARQL $NFLX $AVXL $TQQQ $IQ $DBX $TWTR $UNH $NOK $HMNY $SPXL $MRK $RAD…</nowiki>
+  * <nowiki>RT @Super1NYC: #Premarket Top % Gainers: $ASFI 8%, $ROKU $NFLX $YANG $HMNY $TWTR $TQQQ $ZUO $DGAZ $YNDX $TEO $NOK $PHG $HMY $MRK $IQ $PSEC…</nowiki>
+  * <nowiki>Given the examples in the article, $MRK $RHHBY $PFE $GILD $KITE $SNY $CELG and DOZEN more from $XBI $IBB should be… https://t.co/cB5l1rNwld</nowiki>
+  * <nowiki>$MRK: GapUP 1.25[+2.1%,fill:27%], PrvCl:58.65, PrvHi:59.25, 1NewHi, PDayGp+, 47:6Accel+, allTFs+, bigFlt:2.7B, 1MoHi+, p$vol:3.85M</nowiki>
+  * <nowiki>RT @JSTBiotech: Further $LPTX commentary from Laden - treating physician called one patient's response "a miracle" and Merck $MRK "encourag…</nowiki>
+  * <nowiki>$NVCN Press Release from Feb 2018, March regained compliance with TSX, April Boston SCIENTIFIC, Warrants, May Earni… https://t.co/1Zrt1sMbAP</nowiki>
+  * <nowiki>$MRK Well done. Crossing SMA200.</nowiki>
+  * <nowiki>Merck &amp; Co. $MRK Raised to “Buy” at Morgan Stanley https://t.co/OfgzOYMsAV #stocks</nowiki>
+  * <nowiki>RT @tgtxdough: $MRK #KEYTRUDA Currently have 759 trials listed on https://t.co/0g3i1CrgVf
+o Studying &gt;400 combos
+o 12 breakthrough therapie…</nowiki>
+  * <nowiki>MS $MRK upgrading MRK from EW to OW raising PT from $63 to $68. Keytruda showed better-than-expected KN-189 lung re… https://t.co/35t7vYVxVv</nowiki>
+  * <nowiki>GS - $MRK emerged the clear winner post AACR investor presentation, incremental 10% gain in mkt share (at minimum)… https://t.co/6EeetYjODR</nowiki>
+  * <nowiki>RT @tgtxdough: $MRK #KEYTRUDA Currently have 759 trials listed on https://t.co/0g3i1CrgVf
+o Studying &gt;400 combos
+o 12 breakthrough therapie…</nowiki>
+  * <nowiki>$MRK #KEYTRUDA Currently have 759 trials listed on https://t.co/0g3i1CrgVf
+o Studying &gt;400 combos
+o 12 breakthrough… https://t.co/NGpGOuTWCi</nowiki>
+  * <nowiki>#Premarket Top % Gainers: $CNET 30%, $DPW 15%, $ROKU $ARQL $NFLX $AVXL $TQQQ $IQ $DBX $TWTR $UNH $NOK $HMNY $SPXL… https://t.co/9Hmd2x5bmc</nowiki>
+  * <nowiki>Merck &amp; Co.’s $MRK “Buy” Rating Reaffirmed at BMO Capital Markets https://t.co/ow2AF2hnaE</nowiki>
+  * <nowiki>RT @BioStocks: $MRK upgraded to Overweight at Morgan Stanley. PT $68</nowiki>
+  * <nowiki>Intensity is the price of excellence
+$MYMX The Best Stock Investment For 2018
+HIV Vaccine 100% Effective
+Now At… https://t.co/XRwNiO3ou2</nowiki>
+  * <nowiki>RT @dixielee1969: PM Top % Gainers: $CNET $DPW $ROKU $ARQL $NFLX $AVXL $TQQQ $IQ $DBX $TWTR $UNH $NOK $HMNY $SPXL $MRK $RAD $HMY $BUD $AMD</nowiki>
+  * <nowiki>Target Raised https://t.co/2Wn5XwkMO6 $ICFI $INTC $JBHT $LULU $MA $MB $MNRO $MRK $MTB $NFLX $NUE $RHT $SCHW $STLD $THG $TPR $ULTI $VIAB</nowiki>
+===== $PPL =====
+  * <nowiki>$PPL Stock Quote Alert for PPL Corporation (NYSE:PPL)
+From our Stock News Alerts App</nowiki>
+  * <nowiki>Short volume percent for $XEL on 2018-04-13 is 54%. https://t.co/uLgZeax2Ne $PPL 67% $CMS 45% $AVA 37% $IDA 36%</nowiki>
+  * <nowiki>Scan results - Crossed Above 50 DMA today: $CMMC $ENGH $ITX $U $QBR.B $LXG $SVI $PPL ... https://t.co/g75Ixenriv</nowiki>
+  * <nowiki>$PPL - PPL #PPL Upgraded by Jefferies Group to "Buy" https://t.co/MGLLU3kPqp</nowiki>
+  * <nowiki>PPL $PPL Upgraded by Jefferies Group to “Buy” https://t.co/ZjKiWq5kFT #stocks</nowiki>
+  * <nowiki>$PPL technical alerts: Crossed Above 50 DMA, Stochastic Reached Overbought, and New Uptrend  https://t.co/cKRApFfjhS</nowiki>
+===== $DISCA =====
+  * <nowiki>$DISCA open interest for maturity 04/20/2018. High put=22.50 High call=25.00 #maxpain #options… https://t.co/onPbIQjlS6</nowiki>
+  * <nowiki>Barrington Keeps Their Buy Rating on Discovery Comms $DISCA https://t.co/p4ZBGGrEFE</nowiki>
+  * <nowiki>Discovery $DISCA Given “Buy” Rating at Barrington Research https://t.co/m62DKHu90m #stocks</nowiki>
+===== $DWDP =====
+  * <nowiki>Dow Chemical $DWDP Getting Somewhat Favorable Press Coverage, Accern Reports https://t.co/0LAGCdF0zp</nowiki>
+  * <nowiki>Dow Chemical $DWDP Getting Somewhat Favorable Press Coverage, Accern Reports https://t.co/2OL8v85WuU</nowiki>
+  * <nowiki>SunTrust Banks Weighs in on Dow Chemical’s Q1 2018 Earnings $DWDP https://t.co/8gWSJHYo1Y</nowiki>
+  * <nowiki>SunTrust Banks Weighs in on Dow Chemical’s Q1 2018 Earnings $DWDP https://t.co/mTUR0zTlyl</nowiki>
+  * <nowiki>DowDuPont Inc Gets a Buy Rating from RBC Capital $DWDP https://t.co/EPoC5jOTj6</nowiki>
+  * <nowiki>Dow Chemical's buy rating reiterated at Royal Bank of Canada. $85.00 PT. https://t.co/193zAqppE0 $DWDP #DWDP</nowiki>
+  * <nowiki>Dow Chemical’s $DWDP “Buy” Rating Reiterated at Royal Bank of Canada https://t.co/Tkz7JREze9</nowiki>
+  * <nowiki>Royal Bank of Canada Reaffirms “Buy” Rating for Dow Chemical $DWDP https://t.co/TA0FoYLljz #stocks</nowiki>
+  * <nowiki>Look for investments that are easy to understand
+$MYMX The Best Stock Investment For 2018
+HIV Vaccine 100% Effect… https://t.co/BKMnJMfJDd</nowiki>
+===== $HAL =====
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>Victory Formation Long/Short Portfolio Update - Buy Gold, Oil, And Disney https://t.co/oPD8MfdU1d $DIS, $ADM, $BHP,… https://t.co/ZHYqMBeFtp</nowiki>
+  * <nowiki>Investors Buy Halliburton $HAL on Weakness https://t.co/iAvwsIRRQy</nowiki>
+  * <nowiki>Traders Buy Shares of Halliburton $HAL on Weakness https://t.co/WOHxx4dYIV</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>Money Flows--Buying on Weakness: Among stocks that were ⬇️ Monday, these had the largest net inflows of money $FXI… https://t.co/lKu9dkV98t</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+Mon - $NFLX $BAC
+Tue - $CSX…</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>RT @seeitmarket: NEW Article:  "National Oilwell Varco (NOV) Cycle Outlook: Stock Topping?" - https://t.co/bxXkHkGBQe  by @askSlim
+$NOV $S…</nowiki>
+  * <nowiki>Mammoth Energy Services $TUSK versus Halliburton $HAL Head-To-Head Review https://t.co/cTXbzkc905</nowiki>
+  * <nowiki>RT @Sarge986: Market Recon: Worried About the Trump Scandal? Buy Planet Fitness $XOM $HAL $SLB $PLNT IBM $CSX $LRCX $UAL  https://t.co/b4FR…</nowiki>
+  * <nowiki>Market Recon: Worried About the Trump Scandal? Buy Planet Fitness $XOM $HAL $SLB $PLNT IBM $CSX $LRCX $UAL  https://t.co/b4FREpW5Li</nowiki>
+===== $WING =====
+  * <nowiki>Scan results - Expansion Breakout today: $ERI $CCJ $CVNA $WING $ECL $WRD $ORAN $VLO $KRNT $BT ... https://t.co/nfKdsGhwnd</nowiki>
+  * <nowiki>Scan results - MACD Bullish Signal Line Cross today: $CSU $ILG $WING $LSTR $JBHT $NXST $CRCM $MRTN $ROL $ANTX ... https://t.co/JKIwpnpGfe</nowiki>
+  * <nowiki>Scan results - New 52 Week Closing High today: $ERI $NXEO $VNOM $CVNA $WING $RGNX $ECL $LMNX $LOXO $WRD ... https://t.co/qxDLqvPlq5</nowiki>
+  * <nowiki>Top 5 EPS #WallStreet #Money #Stocks $NAV $JBHT $WING $ALKS $CVS Get Top 20 stocks, Quote &amp; Chart of the Day Free… https://t.co/L7xb3rIsV0</nowiki>
+  * <nowiki>Big Call Activity https://t.co/B6IlNKq3kX $BHGE $WING $JD $SLB $WDC $TPX $IMAX $AMD $MDXG $GM $ALRM $LVS $IPG $AKRX $AMWD $OLED $TWTR $AAPL</nowiki>
+  * <nowiki>All time highs hit
+$BURL $ERI $HLF $LMAT $LULU $RUTH $VLO $WING $WWE $IQ $FTNT $DENN</nowiki>
+===== $MAC =====
+  * <nowiki>#MAC/#BTC:
+Ask: 0.00000429 BTC
+Bid: 0.00000402 BTC
+https://t.co/UQx7PuoCVP
+#Machinecoin #Bitcoin
+$MAC $BTC
+[16.04.2018 21:00:19 UTC]</nowiki>
+I copy "KaizenTrader". Do you?
+➡️ https://t.co/IofCrMrFAM… https://t.co/qWe89gRZZp</nowiki>
+I copy "KaizenTrader". Do you?
+➡️ https://t.co/eoWBlichSy… https://t.co/47ZL1kaaSx</nowiki>
+  * <nowiki>https://t.co/XK3KcE4X4f
+$PND $SPRTS $IND $MAC $FXE $EXN $TRI $EUR $TOKEN $POT $ETB $BLITZ $TSTR $PRN $LUN $PGL… https://t.co/QcOKxI44Uo</nowiki>
+Don't get your coins stolen in the 32nd hack!
+Join… https://t.co/m5J5f409Ly</nowiki>
+  * <nowiki>Brokers Issue Forecasts for Macerich’s FY2019 Earnings $MAC https://t.co/TTSXug54yb</nowiki>
+  * <nowiki>#MAC/#BTC:
+Ask: 0.00000508 BTC
+Bid: 0.00000456 BTC
+https://t.co/UQx7PuoCVP
+#Machinecoin #Bitcoin
+$MAC $BTC
+[17.04.2018 09:00:21 UTC]</nowiki>
+  * <nowiki>⌛️ BINANCE REGISTRATIONS OPEN! ⌛️
+Register RIGHT NOW at the #1 Crypto Exchange:
+➡️ https://t.co/KXOSJeYkWE ⬅️
+(P… https://t.co/M9bzfz1V9N</nowiki>
+  * <nowiki>Analysts Anticipate Macerich $MAC to Post $0.81 Earnings Per Share https://t.co/Tj0FKfAtZQ</nowiki>
+  * <nowiki>Macerich $MAC Expected to Announce Earnings of $0.81 Per Share https://t.co/XUYPVzFJGN</nowiki>
+===== $NAV =====
+  * <nowiki>RT @Super1NYC: Top % Gainers: $CGIX 37%, $HMNY 31%, $I $ERI $CVNA $HEAR $EBIO $SRNE $TRNC $UEC $WATT $NAV $CRON $PCRX $ILG $MDXG $JBHT $TND…</nowiki>
+  * <nowiki>RT @theflynews: On The Fly: Top stock stories for Monday $AMZN $CVS $WBA $ABC $MCK $CAH $TSLA $NFLX $BAC $WPP $ERI $TPCA $NAV $VLKAY $ACIA…</nowiki>
+  * <nowiki>RT @theflynews: On The Fly: Top stock stories for Monday $AMZN $CVS $WBA $ABC $MCK $CAH $TSLA $NFLX $BAC $WPP $ERI $TPCA $NAV $VLKAY $ACIA…</nowiki>
+  * <nowiki>RT @SwingTradeBot: Scan results - MACD Bullish Centerline Cross today: $NAV $GWPH $MRTN $KRNT $CE $EPD $COST $LUK $ALSN $UNH ... https://t.…</nowiki>
+  * <nowiki>Scan results - MACD Bullish Centerline Cross today: $NAV $GWPH $MRTN $KRNT $CE $EPD $COST $LUK $ALSN $UNH ... https://t.co/YN1VrBWUAJ</nowiki>
+  * <nowiki>Scan results - Crossed Above 50 DMA today: $NAV $ILG $JBHT $GNRC $MCK $VMW $ATUS $AOS $DCP $HUBG ... https://t.co/QklaH8Cvyb</nowiki>
+  * <nowiki>RT @ProfitTradeRoom: 1️⃣2️⃣Biggest Market Gainers $CGIX $HMNY $I $ERI $PSDV $HEAR $EBIO $EYEG $SRNE $UEC $NAV $WATT $ARGS $CRON $JONE $NM $…</nowiki>
+  * <nowiki>1️⃣2️⃣Biggest Market Gainers $CGIX $HMNY $I $ERI $PSDV $HEAR $EBIO $EYEG $SRNE $UEC $NAV $WATT $ARGS $CRON $JONE… https://t.co/sbJuZm2ReF</nowiki>
+  * <nowiki>Top 5 EPS #WallStreet #Money #Stocks $NAV $JBHT $WING $ALKS $CVS Get Top 20 stocks, Quote &amp; Chart of the Day Free… https://t.co/L7xb3rIsV0</nowiki>
+  * <nowiki>Join our pump group for fast bitcoin
+https://t.co/sFUodj0HoC
+$NAV $EOS $ZEC $ELF $XZC $MCO $ETH $HSR $BTG $CTR… https://t.co/TruyjLAmxV</nowiki>
+  * <nowiki>Join our biggest pump Binance group
+https://t.co/qGQzcfEJ7Y
+$BNT $TRX $IOTA $CDT $MCO $BCC $BCPT $NAV $XLM $LUN… https://t.co/rrRs7dcQJy</nowiki>
+  * <nowiki>Join our biggest pump Binance group
+https://t.co/hZ4Z0HtoeE
+$NEO $ZRX $ICN $BCC $LTC $DASH $VIBE $ARN $OST $NAV… https://t.co/eSzfRiqUdm</nowiki>
+  * <nowiki>Gainers $CGIX $HMNY $ERI $PSDV $HEAR $EBIO $EYEG $SRNE $UEC $NAV $WATT $ARGS $CRON $JONE $NM $PCRX $ILG $MDXG $TSRO… https://t.co/kwBZHEC2xS</nowiki>
+  * <nowiki>RT @Super1NYC: Top % Gainers: $CGIX 40%, $RGSE 26%, $ERI $I $FSCT $FTD $ENT $HEAR $NAV $APTO $RGNX $TRNC $MVIS $RUBI $CVNA $LGCY $APRN $LOX…</nowiki>
+  * <nowiki>RT @pennystockprodi: $ERI $CVNA $HEAR $EBIO $SRNE $TRNC $UEC $WATT $NAV $CRON $PCRX $ILG $MDXG $JBHT $TNDM $TSRO $WRD $GPRO  Exactly why Ma…</nowiki>
+  * <nowiki>$ERI $CVNA $HEAR $EBIO $SRNE $TRNC $UEC $WATT $NAV $CRON $PCRX $ILG $MDXG $JBHT $TNDM $TSRO $WRD $GPRO  Exactly why… https://t.co/xHYRAwJ6zN</nowiki>
+  * <nowiki>We made 25% with our last pump signal
+https://t.co/EfgxBYA97d
+$LSK $BRD $IOTA $MCO $OMG $EOS $BQX $NAV $POE $BTC… https://t.co/hP7ui2ypqp</nowiki>
+  * <nowiki>We will pump on binance at 10PM
+https://t.co/B1gw2ZUEuW
+$WINGS $DNT $POE $GAS $HSR $ETH $QSP $MOD $NAV $NEBL $KMD… https://t.co/dKslX9Y9Ex</nowiki>
+  * <nowiki>We will pump on binance at 10PM
+https://t.co/oS9bj7nVQY
+$STORJ $BRD $REQ $XRP $XMR $ELF $XLM $NAV $OCN $AMB $BNT… https://t.co/1Uxx7AaEly</nowiki>
+  * <nowiki>We will pump coin on Binance today
+https://t.co/UnQhmXKyve
+$BQX $NEBL $DASH $BTG $CND $NAV $XRP $MTL $OCN $DGD… https://t.co/t9h5t4HpPq</nowiki>
+  * <nowiki>Top Gainers $CGIX $HMNY $ERI $PSDV $HEAR $EBIO $EYEG $SRNE $UEC $NAV $WATT $ARGS $CRON $JONE $NM $PCRX $ILG $MDXG $TSRO $TNDM $JBHT $RGSE</nowiki>
+  * <nowiki>RT @CoinSignalBot: 30 min #RSI Signals:
+$BTC - $GBG: 33.98
+$BTC - $DCR: 36.88
+$BTC - $SRN: 38.89
+$BTC - $ZEC: 39.24
+$BTC - $NAV: 41.57
+$BT…</nowiki>
+  * <nowiki>30 min #RSI Signals:
+$BTC - $GBG: 33.98
+$BTC - $DCR: 36.88
+$BTC - $SRN: 38.89
+$BTC - $ZEC: 39.24
+$BTC - $NAV: 41.5… https://t.co/yrIi5YGpP0</nowiki>
+  * <nowiki>Join our pump group for fast bitcoin
+https://t.co/hZ31I7rcP0
+$FUEL $TRX $LEND $NAV $ETH $OMG $BRD $NANO $LUN $ARK… https://t.co/mzR5olufsS</nowiki>
+  * <nowiki>Join our pump group for fast bitcoin
+https://t.co/TV8epcEHKY
+$ENJ $MDA $KNC $WINGS $BRD $MCO $ONT $GXS $NAV $EDO… https://t.co/vprhQNRvL9</nowiki>
+===== $DVA =====
+  * <nowiki>$IHF Good day for health care providers. Broke downtrend and above key moving averages for first time in a month. A… https://t.co/XHUssi9J9C</nowiki>
+  * <nowiki>Contrasting Davita $DVA &amp; Caladrius Biosciences $CLBS https://t.co/8O2iSYxE7W</nowiki>
+  * <nowiki>Head-To-Head Survey: Davita $DVA versus Caladrius Biosciences $CLBS https://t.co/MnYQM0nZpT</nowiki>
+  * <nowiki>Head-To-Head Survey: Davita $DVA versus Caladrius Biosciences $CLBS https://t.co/FxsSWccm4I #stocks</nowiki>
+  * <nowiki>$DVA Max Pain is 67.50 for maturity 04/20/2018. #maxpain #options https://t.co/j8AruYRhAf https://t.co/dXVsoEzg7N</nowiki>
+  * <nowiki>Reviewing Davita $DVA &amp; Catasys $CATS https://t.co/0aV2D8EdRj #stocks</nowiki>
+  * <nowiki>Catasys $CATS versus Davita $DVA Head to Head Comparison https://t.co/HzrpXM8nVY</nowiki>
+  * <nowiki>Reviewing Davita $DVA &amp; Catasys $CATS https://t.co/4WdiR1X4iR</nowiki>
+  * <nowiki>Reviewing Davita $DVA &amp; Catasys $CATS https://t.co/sK96VKVBwJ</nowiki>
+  * <nowiki>$DVA DaVita Inc. Schedules 1st Quarter 2018 Investor Conference Call
+From our Stock News Alerts App</nowiki>
+===== $MRTN =====
+  * <nowiki>RT @SwingTradeBot: Scan results - MACD Bullish Centerline Cross today: $NAV $GWPH $MRTN $KRNT $CE $EPD $COST $LUK $ALSN $UNH ... https://t.…</nowiki>
+  * <nowiki>Scan results - MACD Bullish Centerline Cross today: $NAV $GWPH $MRTN $KRNT $CE $EPD $COST $LUK $ALSN $UNH ... https://t.co/YN1VrBWUAJ</nowiki>
+  * <nowiki>Scan results - MACD Bullish Signal Line Cross today: $CSU $ILG $WING $LSTR $JBHT $NXST $CRCM $MRTN $ROL $ANTX ... https://t.co/JKIwpnpGfe</nowiki>

Differences

Search